- Meeting abstract
- Open Access
Miniplegia versus blood cardioplegia in elective aortic valve replacement: a prospective randomised, non - inferiority controlled trial
© Bernabeu et al. 2015
- Published: 16 December 2015
- Sinus Rhythm
- Postoperative Mortality
- Myocardial Protection
- Blood Cardioplegia
- Preoperative Variable
Antegrade intermittent 4:1 blood cardioplegia with Buckberg solution is widely used in elective aortic valve replacement. Use of miniplegia could simplify myocardial protection in this setting.
Our objective was to compare both strategies in terms of non-inferiority.
A prospective, randomised controlled trial was performed. Primary end-point was demonstrating non-inferiority of miniplegia versus intermittent 4:1 blood cardioplegia in elective aortic valve replacement. For sample size calculation, a maximum increase +15% in mean peak postoperative troponin T was considered non-inferior (Δ = +474.24 ng/L). Power was 0.9, and α < 0.05 was considered statistically significant. Secondary end-points were differences in troponin curve, reperfusion and postoperative rhythm, haematocrit, use of inotropic and vasopressor drug support, ICU stay, and postoperative evolution.
66 patients were enrolled and randomised. There were no significant differences in baseline and preoperative variables. Peak troponin T in miniplegia group was non-inferior to blood cardioplegia group (p = 0.036). Patients in the miniplegia group showed a higher incidence of spontaneous sinus rhythm after myocardial ischemia (18/33, 54.5% versus 8/33, 24.2%, p = 0.005) and fewer patients required defibrillation (9/33, 27.7% versus 21/33, 63.6%, p = 0.03) for ventricular reperfusion arrhythmias. Postoperatively, there were no differences in troponin T release, inotropic and vasopressor drug support, ICU stay, and postoperative mortality.
Miniplegia used as myocardial protection in elective aortic replacement is non-inferior to blood cardioplegia. Preferential return to sinus rhythm and lower incidence of reperfusion arrhythmias in the miniplegia group could reflect a better myocardial protection during cardioplegic arrest. Ease of administration and inexpensive use of miniplegia are additional benefits.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.